According to Zimmer Biomet's latest financial reports the company has a price-to-book ratio of 1.96.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 2.04 | -8.45% |
2022-12-31 | 2.22 | 6.18% |
2021-12-31 | 2.10 | -19.97% |
2020-12-31 | 2.62 | 5.23% |
2019-12-31 | 2.49 | 32.6% |
2018-12-31 | 1.88 | -9.87% |
2017-12-31 | 2.08 | -2.61% |
2016-12-31 | 2.14 | 1.66% |
2015-12-31 | 2.10 | -28.42% |
2014-12-31 | 2.94 | 16.97% |
2013-12-31 | 2.51 | 28.81% |
2012-12-31 | 1.95 | 12.35% |
2011-12-31 | 1.74 | -4.6% |
2010-12-31 | 1.82 | -15.01% |
2009-12-31 | 2.14 | 33.33% |
2008-12-31 | 1.61 | -43.18% |
2007-12-31 | 2.83 | -25.05% |
2006-12-31 | 3.77 | 5.69% |
2005-12-31 | 3.57 | -28.38% |
2004-12-31 | 4.98 | -8.06% |
2003-12-31 | 5.42 | -75.52% |
2002-12-31 | 22.1 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Edwards Lifesciences EW | 7.74 | 294.45% | ๐บ๐ธ USA |
Stryker Corporation SYK | 6.70 | 241.30% | ๐บ๐ธ USA |
Cooper Companies COO | 2.34 | 18.94% | ๐บ๐ธ USA |
Dentsply Sirona
XRAY | 1.92 | -2.27% | ๐บ๐ธ USA |